Flag­ship opens hub, plants roots in the UK as gov­ern­ment aims to boost life sci­ence ecosys­tem

Flag­ship Pi­o­neer­ing — the plat­form com­pa­ny be­hind the likes of Mod­er­na and Seres Ther­a­peu­tics — launched a UK hub on Tues­day as part of its broad­er com­mit­ment to in­vest­ing in the UK life sci­ence space.

The com­pa­ny marked the open­ing with an event in Lon­don co-host­ed by the UK Gov­ern­ment’s Of­fice for Life Sci­ences with a fo­cus on the top­ic of break­through in­no­va­tions. The event fol­lows just a week af­ter Flag­ship un­veiled its first transat­lantic biotech com­pa­ny, Quo­tient Ther­a­peu­tics, which has a so­mat­ic ge­nomics plat­form de­signed to dis­cov­er nov­el drug tar­gets across a range of ther­a­peu­tic ar­eas.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER